

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vocalization behavior (GO:0071625) | 3.96379077 |
| 2 | synaptic vesicle maturation (GO:0016188) | 3.79254774 |
| 3 | bile acid and bile salt transport (GO:0015721) | 3.68338538 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.67856283 |
| 5 | regulation of ARF protein signal transduction (GO:0032012) | 3.62369640 |
| 6 | locomotory exploration behavior (GO:0035641) | 3.61007270 |
| 7 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.57193261 |
| 8 | sulfur amino acid catabolic process (GO:0000098) | 3.41290146 |
| 9 | glutamate secretion (GO:0014047) | 3.29999368 |
| 10 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.25184136 |
| 11 | sodium ion export (GO:0071436) | 3.24418516 |
| 12 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.23308509 |
| 13 | barbed-end actin filament capping (GO:0051016) | 3.22571914 |
| 14 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.18292147 |
| 15 | cell communication involved in cardiac conduction (GO:0086065) | 3.16401468 |
| 16 | cell communication by electrical coupling (GO:0010644) | 3.14376513 |
| 17 | L-phenylalanine catabolic process (GO:0006559) | 3.13411428 |
| 18 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.13411428 |
| 19 | kynurenine metabolic process (GO:0070189) | 3.12583258 |
| 20 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.11781113 |
| 21 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.11126691 |
| 22 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.09917683 |
| 23 | regulation of synapse structural plasticity (GO:0051823) | 3.06664469 |
| 24 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.05468525 |
| 25 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.02754579 |
| 26 | L-phenylalanine metabolic process (GO:0006558) | 3.02754579 |
| 27 | cellular ketone body metabolic process (GO:0046950) | 3.00670748 |
| 28 | alpha-linolenic acid metabolic process (GO:0036109) | 2.99440971 |
| 29 | regulation of cholesterol homeostasis (GO:2000188) | 2.96803867 |
| 30 | positive regulation of synapse maturation (GO:0090129) | 2.95039541 |
| 31 | activation of protein kinase A activity (GO:0034199) | 2.93681054 |
| 32 | lysine metabolic process (GO:0006553) | 2.93280809 |
| 33 | lysine catabolic process (GO:0006554) | 2.93280809 |
| 34 | carnitine shuttle (GO:0006853) | 2.87350217 |
| 35 | neurotransmitter secretion (GO:0007269) | 2.84743849 |
| 36 | aromatic amino acid family catabolic process (GO:0009074) | 2.84667394 |
| 37 | fatty acid transmembrane transport (GO:1902001) | 2.84420377 |
| 38 | synaptic vesicle exocytosis (GO:0016079) | 2.80490822 |
| 39 | cellular potassium ion homeostasis (GO:0030007) | 2.77903536 |
| 40 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.77890780 |
| 41 | cerebellar granule cell differentiation (GO:0021707) | 2.72128980 |
| 42 | bile acid biosynthetic process (GO:0006699) | 2.71781018 |
| 43 | glutamate metabolic process (GO:0006536) | 2.71375849 |
| 44 | alanine transport (GO:0032328) | 2.71135463 |
| 45 | phospholipid homeostasis (GO:0055091) | 2.70345896 |
| 46 | gamma-aminobutyric acid transport (GO:0015812) | 2.69991482 |
| 47 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.69368000 |
| 48 | L-amino acid import (GO:0043092) | 2.69363951 |
| 49 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.68267300 |
| 50 | mannose metabolic process (GO:0006013) | 2.67344562 |
| 51 | high-density lipoprotein particle remodeling (GO:0034375) | 2.66081424 |
| 52 | negative regulation of fibrinolysis (GO:0051918) | 2.64448725 |
| 53 | indolalkylamine catabolic process (GO:0046218) | 2.63021621 |
| 54 | tryptophan catabolic process (GO:0006569) | 2.63021621 |
| 55 | indole-containing compound catabolic process (GO:0042436) | 2.63021621 |
| 56 | bile acid metabolic process (GO:0008206) | 2.62552206 |
| 57 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.62424472 |
| 58 | regulation of triglyceride catabolic process (GO:0010896) | 2.61771788 |
| 59 | positive regulation of lipid catabolic process (GO:0050996) | 2.61192527 |
| 60 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.60599919 |
| 61 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.60214858 |
| 62 | proline transport (GO:0015824) | 2.59461952 |
| 63 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.58773845 |
| 64 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.58253746 |
| 65 | ketone body metabolic process (GO:1902224) | 2.57972794 |
| 66 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.56981292 |
| 67 | glyoxylate metabolic process (GO:0046487) | 2.56678492 |
| 68 | complement activation, alternative pathway (GO:0006957) | 2.56671322 |
| 69 | regulation of synapse maturation (GO:0090128) | 2.56482899 |
| 70 | regulation of protein activation cascade (GO:2000257) | 2.55334384 |
| 71 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.55326926 |
| 72 | cellular sodium ion homeostasis (GO:0006883) | 2.54989063 |
| 73 | urea cycle (GO:0000050) | 2.54549125 |
| 74 | urea metabolic process (GO:0019627) | 2.54549125 |
| 75 | ethanol oxidation (GO:0006069) | 2.53665317 |
| 76 | 2-oxoglutarate metabolic process (GO:0006103) | 2.52012506 |
| 77 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.51753955 |
| 78 | protein carboxylation (GO:0018214) | 2.51753955 |
| 79 | amino acid import (GO:0043090) | 2.51747502 |
| 80 | positive regulation of protein dephosphorylation (GO:0035307) | 2.50760776 |
| 81 | negative regulation of sterol transport (GO:0032372) | 2.50704407 |
| 82 | negative regulation of cholesterol transport (GO:0032375) | 2.50704407 |
| 83 | exploration behavior (GO:0035640) | 2.49181477 |
| 84 | axonemal dynein complex assembly (GO:0070286) | 2.49061376 |
| 85 | protein localization to endosome (GO:0036010) | 2.48346115 |
| 86 | protein-lipid complex remodeling (GO:0034368) | 2.47887994 |
| 87 | macromolecular complex remodeling (GO:0034367) | 2.47887994 |
| 88 | plasma lipoprotein particle remodeling (GO:0034369) | 2.47887994 |
| 89 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.47357368 |
| 90 | short-chain fatty acid metabolic process (GO:0046459) | 2.47323966 |
| 91 | positive regulation of fatty acid oxidation (GO:0046321) | 2.47235797 |
| 92 | stress fiber assembly (GO:0043149) | 2.47216237 |
| 93 | cellular glucuronidation (GO:0052695) | 2.46091395 |
| 94 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.45668982 |
| 95 | regulation of synaptic vesicle transport (GO:1902803) | 2.45176070 |
| 96 | dicarboxylic acid catabolic process (GO:0043649) | 2.43596835 |
| 97 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.43315468 |
| 98 | signal complex assembly (GO:0007172) | 2.43005860 |
| 99 | low-density lipoprotein particle clearance (GO:0034383) | 2.42995564 |
| 100 | protein targeting to plasma membrane (GO:0072661) | 2.42969892 |
| 101 | positive regulation of Rap GTPase activity (GO:0032854) | 2.42963315 |
| 102 | positive regulation of extracellular matrix organization (GO:1903055) | 2.42751203 |
| 103 | low-density lipoprotein particle remodeling (GO:0034374) | 2.42667644 |
| 104 | cardiac conduction (GO:0061337) | 2.42584999 |
| 105 | layer formation in cerebral cortex (GO:0021819) | 2.42394064 |
| 106 | extracellular fibril organization (GO:0043206) | 2.42002760 |
| 107 | regulation of fibrinolysis (GO:0051917) | 2.41932178 |
| 108 | ethanol metabolic process (GO:0006067) | 2.41930125 |
| 109 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.40994900 |
| 110 | aspartate family amino acid catabolic process (GO:0009068) | 2.40965135 |
| 111 | regulation of complement activation (GO:0030449) | 2.40154119 |
| 112 | tryptophan metabolic process (GO:0006568) | 2.40130280 |
| 113 | regulation of ARF GTPase activity (GO:0032312) | 2.39964063 |
| 114 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.39763143 |
| 115 | fibril organization (GO:0097435) | 2.39355321 |
| 116 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.38965939 |
| 117 | adenosine receptor signaling pathway (GO:0001973) | 2.38310748 |
| 118 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.37652779 |
| 119 | negative regulation of cell killing (GO:0031342) | 2.37652779 |
| 120 | potassium ion import (GO:0010107) | 2.36383881 |
| 121 | cellular modified amino acid catabolic process (GO:0042219) | 2.36254795 |
| 122 | tricarboxylic acid cycle (GO:0006099) | 2.36068765 |
| 123 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.35985522 |
| 124 | regulation of fatty acid oxidation (GO:0046320) | 2.35131755 |
| 125 | glycine transport (GO:0015816) | 2.34513664 |
| 126 | succinate metabolic process (GO:0006105) | 2.34176841 |
| 127 | neuronal ion channel clustering (GO:0045161) | 2.32180684 |
| 128 | reverse cholesterol transport (GO:0043691) | 2.31978062 |
| 129 | cell volume homeostasis (GO:0006884) | 2.31811019 |
| 130 | positive regulation of fibroblast migration (GO:0010763) | 2.31804489 |
| 131 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.31608182 |
| 132 | regulation of neurotransmitter levels (GO:0001505) | 2.31130483 |
| 133 | drug catabolic process (GO:0042737) | 2.30939005 |
| 134 | cellular response to epinephrine stimulus (GO:0071872) | 2.29562101 |
| 135 | neuromuscular process controlling balance (GO:0050885) | 2.27905488 |
| 136 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.27786892 |
| 137 | regulation of extracellular matrix disassembly (GO:0010715) | 2.27637892 |
| 138 | actin filament capping (GO:0051693) | 2.26864943 |
| 139 | regulation of synaptic plasticity (GO:0048167) | 2.26707980 |
| 140 | diacylglycerol metabolic process (GO:0046339) | 2.24399232 |
| 141 | apoptotic cell clearance (GO:0043277) | 2.24230861 |
| 142 | motile cilium assembly (GO:0044458) | 2.22567915 |
| 143 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.18187317 |
| 144 | protein heterotrimerization (GO:0070208) | 2.17160198 |
| 145 | regulation of early endosome to late endosome transport (GO:2000641) | 2.15199474 |
| 146 | cellular response to monoamine stimulus (GO:0071868) | 2.14338136 |
| 147 | cellular response to catecholamine stimulus (GO:0071870) | 2.14338136 |
| 148 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.12469966 |
| 149 | adherens junction assembly (GO:0034333) | 2.12348967 |
| 150 | focal adhesion assembly (GO:0048041) | 2.12096240 |
| 151 | cell-substrate adherens junction assembly (GO:0007045) | 2.12096240 |
| 152 | extracellular matrix assembly (GO:0085029) | 2.11665314 |
| 153 | cGMP-mediated signaling (GO:0019934) | 2.11283902 |
| 154 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.10994264 |
| 155 | positive regulation of dendritic spine development (GO:0060999) | 2.09450201 |
| 156 | positive regulation of receptor recycling (GO:0001921) | 2.08898633 |
| 157 | response to acidic pH (GO:0010447) | 2.04388031 |
| 158 | regulation of Rap GTPase activity (GO:0032317) | 2.03934781 |
| 159 | cortical actin cytoskeleton organization (GO:0030866) | 2.03848563 |
| 160 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.03735236 |
| 161 | neutral lipid catabolic process (GO:0046461) | 2.02707951 |
| 162 | acylglycerol catabolic process (GO:0046464) | 2.02707951 |
| 163 | regulation of response to osmotic stress (GO:0047484) | 2.01751347 |
| 164 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.01480332 |
| 165 | potassium ion homeostasis (GO:0055075) | 2.00383977 |
| 166 | detection of calcium ion (GO:0005513) | 2.00036709 |
| 167 | regulation of T-helper 2 cell differentiation (GO:0045628) | 1.99118572 |
| 168 | dopamine receptor signaling pathway (GO:0007212) | 1.97094499 |
| 169 | positive regulation of membrane potential (GO:0045838) | 1.96867406 |
| 170 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 1.96652811 |
| 171 | triglyceride catabolic process (GO:0019433) | 1.95501201 |
| 172 | negative regulation of inclusion body assembly (GO:0090084) | 1.94146246 |
| 173 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 1.92985925 |
| 174 | cAMP biosynthetic process (GO:0006171) | 1.92376231 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.62014828 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.27497172 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.83405171 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.76828542 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.71917987 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.47737730 |
| 7 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.32621319 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.28333255 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.23196916 |
| 10 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.21882702 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.14989062 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.11585856 |
| 13 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.88130783 |
| 14 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.86774025 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.85834688 |
| 16 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.85623388 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.84809835 |
| 18 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.84784137 |
| 19 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.84694573 |
| 20 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.84230596 |
| 21 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.72947021 |
| 22 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.72947021 |
| 23 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.70103440 |
| 24 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.68580172 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.66503234 |
| 26 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.64538530 |
| 27 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.63325921 |
| 28 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.62627517 |
| 29 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.62406772 |
| 30 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.59528748 |
| 31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.57777793 |
| 32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.56061427 |
| 33 | P68_20966046_ChIP-Seq_HELA_Human | 1.54891298 |
| 34 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.54334445 |
| 35 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.52330761 |
| 36 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.51717764 |
| 37 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.51649630 |
| 38 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.50325884 |
| 39 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.49716845 |
| 40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.49210600 |
| 41 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.47048839 |
| 42 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.44856385 |
| 43 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.42890762 |
| 44 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40603080 |
| 45 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.40381298 |
| 46 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.38992231 |
| 47 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.38697746 |
| 48 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.38669252 |
| 49 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.36810544 |
| 50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.35719183 |
| 51 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.35059534 |
| 52 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.34411919 |
| 53 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.32956290 |
| 54 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.32327855 |
| 55 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.31089207 |
| 56 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.30605695 |
| 57 | KDM2B_26808549_Chip-Seq_K562_Human | 1.28797969 |
| 58 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.28473034 |
| 59 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.26438571 |
| 60 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.26275891 |
| 61 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.25257363 |
| 62 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.23838522 |
| 63 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.23098777 |
| 64 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.21157655 |
| 65 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.19621777 |
| 66 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.17549657 |
| 67 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.17004038 |
| 68 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.16000272 |
| 69 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15514407 |
| 70 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15432522 |
| 71 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.13210665 |
| 72 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.12745619 |
| 73 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.10819541 |
| 74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10798448 |
| 75 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10573424 |
| 76 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.10072213 |
| 77 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.09818807 |
| 78 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.09442987 |
| 79 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.09411318 |
| 80 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.07555561 |
| 81 | SA1_27219007_Chip-Seq_Bcells_Human | 1.07069224 |
| 82 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05853498 |
| 83 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.05420125 |
| 84 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.04814156 |
| 85 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.03350326 |
| 86 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.03309255 |
| 87 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.03165124 |
| 88 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02769637 |
| 89 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02426411 |
| 90 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.02414911 |
| 91 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02291028 |
| 92 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.02239491 |
| 93 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.01607817 |
| 94 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.01355859 |
| 95 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.01068526 |
| 96 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00374396 |
| 97 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.00041940 |
| 98 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.99792749 |
| 99 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.99347822 |
| 100 | MAF_26560356_Chip-Seq_TH1_Human | 0.99110117 |
| 101 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.98968615 |
| 102 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98849699 |
| 103 | MAF_26560356_Chip-Seq_TH2_Human | 0.98754248 |
| 104 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.97536457 |
| 105 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.97441811 |
| 106 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.95724399 |
| 107 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.95662986 |
| 108 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.94670290 |
| 109 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93057462 |
| 110 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92260740 |
| 111 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91595453 |
| 112 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.91371944 |
| 113 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91076054 |
| 114 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.91034933 |
| 115 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90984355 |
| 116 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.90456333 |
| 117 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88709479 |
| 118 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88126811 |
| 119 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.87629082 |
| 120 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.87543221 |
| 121 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.86497748 |
| 122 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.86420409 |
| 123 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.86150085 |
| 124 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.85903688 |
| 125 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.85863529 |
| 126 | AR_19668381_ChIP-Seq_PC3_Human | 0.85130160 |
| 127 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.84787133 |
| 128 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.84566574 |
| 129 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.84566574 |
| 130 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.83697307 |
| 131 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.82269146 |
| 132 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.81919678 |
| 133 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.81625559 |
| 134 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.81290341 |
| 135 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.81290341 |
| 136 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.80484789 |
| 137 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80151662 |
| 138 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.80134402 |
| 139 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.79455713 |
| 140 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.79421814 |
| 141 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.77849808 |
| 142 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.77794390 |
| 143 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.76027655 |
| 144 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.74486664 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.41474331 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 4.00278402 |
| 3 | MP0002822_catalepsy | 3.76886664 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.73321653 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.68215011 |
| 6 | MP0005360_urolithiasis | 3.47378956 |
| 7 | MP0005365_abnormal_bile_salt | 3.08360678 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 2.97839367 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 2.76348052 |
| 10 | MP0001958_emphysema | 2.68954249 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.50691979 |
| 12 | MP0003252_abnormal_bile_duct | 2.35989989 |
| 13 | MP0003635_abnormal_synaptic_transmissio | 2.29408520 |
| 14 | MP0003279_aneurysm | 2.27633757 |
| 15 | MP0010329_abnormal_lipoprotein_level | 2.24493213 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 2.14154233 |
| 17 | MP0002909_abnormal_adrenal_gland | 2.09980561 |
| 18 | MP0004270_analgesia | 2.09263291 |
| 19 | MP0000751_myopathy | 2.02970694 |
| 20 | MP0005670_abnormal_white_adipose | 1.93627990 |
| 21 | MP0005503_abnormal_tendon_morphology | 1.90889319 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 1.86168227 |
| 23 | MP0004130_abnormal_muscle_cell | 1.84257633 |
| 24 | MP0005167_abnormal_blood-brain_barrier | 1.82237233 |
| 25 | MP0005623_abnormal_meninges_morphology | 1.81939056 |
| 26 | MP0009840_abnormal_foam_cell | 1.78685147 |
| 27 | MP0009745_abnormal_behavioral_response | 1.77330609 |
| 28 | MP0002063_abnormal_learning/memory/cond | 1.76860607 |
| 29 | MP0003329_amyloid_beta_deposits | 1.76689060 |
| 30 | MP0005423_abnormal_somatic_nervous | 1.72738617 |
| 31 | MP0005058_abnormal_lysosome_morphology | 1.71263306 |
| 32 | MP0004858_abnormal_nervous_system | 1.60550293 |
| 33 | MP0000604_amyloidosis | 1.59763926 |
| 34 | MP0005275_abnormal_skin_tensile | 1.57595153 |
| 35 | MP0003806_abnormal_nucleotide_metabolis | 1.57124889 |
| 36 | MP0004215_abnormal_myocardial_fiber | 1.56740924 |
| 37 | MP0005409_darkened_coat_color | 1.56697042 |
| 38 | MP0001501_abnormal_sleep_pattern | 1.53536689 |
| 39 | MP0002064_seizures | 1.53112101 |
| 40 | MP0003303_peritoneal_inflammation | 1.51991634 |
| 41 | MP0003075_altered_response_to | 1.51926875 |
| 42 | MP0003172_abnormal_lysosome_physiology | 1.51592356 |
| 43 | MP0004084_abnormal_cardiac_muscle | 1.51506805 |
| 44 | MP0003646_muscle_fatigue | 1.50516341 |
| 45 | MP0002933_joint_inflammation | 1.49826075 |
| 46 | MP0002118_abnormal_lipid_homeostasis | 1.48695141 |
| 47 | MP0005083_abnormal_biliary_tract | 1.47295791 |
| 48 | MP0001666_abnormal_nutrient_absorption | 1.47234462 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.46232377 |
| 50 | MP0009046_muscle_twitch | 1.45122834 |
| 51 | MP0004036_abnormal_muscle_relaxation | 1.44789708 |
| 52 | MP0003195_calcinosis | 1.41445129 |
| 53 | MP0005332_abnormal_amino_acid | 1.39071803 |
| 54 | MP0000920_abnormal_myelination | 1.38514917 |
| 55 | MP0003436_decreased_susceptibility_to | 1.38241495 |
| 56 | MP0003724_increased_susceptibility_to | 1.36639267 |
| 57 | MP0003091_abnormal_cell_migration | 1.35863342 |
| 58 | MP0003283_abnormal_digestive_organ | 1.35611940 |
| 59 | MP0005375_adipose_tissue_phenotype | 1.29642623 |
| 60 | MP0001968_abnormal_touch/_nociception | 1.26752958 |
| 61 | MP0002734_abnormal_mechanical_nocicepti | 1.26203493 |
| 62 | MP0003566_abnormal_cell_adhesion | 1.25612251 |
| 63 | MP0003879_abnormal_hair_cell | 1.24657109 |
| 64 | MP0002572_abnormal_emotion/affect_behav | 1.24231906 |
| 65 | MP0002272_abnormal_nervous_system | 1.22323488 |
| 66 | MP0001849_ear_inflammation | 1.22123791 |
| 67 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.21514710 |
| 68 | MP0000013_abnormal_adipose_tissue | 1.21113896 |
| 69 | MP0003868_abnormal_feces_composition | 1.19575215 |
| 70 | MP0003880_abnormal_central_pattern | 1.17901473 |
| 71 | MP0002269_muscular_atrophy | 1.15789417 |
| 72 | MP0010368_abnormal_lymphatic_system | 1.14592774 |
| 73 | MP0005330_cardiomyopathy | 1.14465341 |
| 74 | MP0008569_lethality_at_weaning | 1.13071529 |
| 75 | MP0003690_abnormal_glial_cell | 1.12716676 |
| 76 | MP0005319_abnormal_enzyme/_coenzyme | 1.12657079 |
| 77 | MP0001486_abnormal_startle_reflex | 1.12501034 |
| 78 | MP0001440_abnormal_grooming_behavior | 1.11797636 |
| 79 | MP0000003_abnormal_adipose_tissue | 1.11588457 |
| 80 | MP0008260_abnormal_autophagy | 1.10939186 |
| 81 | MP0004272_abnormal_basement_membrane | 1.10480138 |
| 82 | MP0001348_abnormal_lacrimal_gland | 1.10129495 |
| 83 | MP0003633_abnormal_nervous_system | 1.09000051 |
| 84 | MP0002998_abnormal_bone_remodeling | 1.07504779 |
| 85 | MP0000749_muscle_degeneration | 1.06605165 |
| 86 | MP0005388_respiratory_system_phenotype | 1.05725561 |
| 87 | MP0002133_abnormal_respiratory_system | 1.05725561 |
| 88 | MP0003137_abnormal_impulse_conducting | 1.05594447 |
| 89 | MP0005166_decreased_susceptibility_to | 1.05516384 |
| 90 | MP0001533_abnormal_skeleton_physiology | 1.04944371 |
| 91 | MP0004087_abnormal_muscle_fiber | 1.04672605 |
| 92 | MP0005165_increased_susceptibility_to | 1.04604369 |
| 93 | MP0002295_abnormal_pulmonary_circulatio | 1.03991988 |
| 94 | MP0005620_abnormal_muscle_contractility | 1.02517307 |
| 95 | MP0005595_abnormal_vascular_smooth | 1.02037672 |
| 96 | MP0002972_abnormal_cardiac_muscle | 1.01411089 |
| 97 | MP0004484_altered_response_of | 1.01374120 |
| 98 | MP0003828_pulmonary_edema | 1.01332740 |
| 99 | MP0000609_abnormal_liver_physiology | 0.99759853 |
| 100 | MP0008874_decreased_physiological_sensi | 0.99692572 |
| 101 | MP0005535_abnormal_body_temperature | 0.98932873 |
| 102 | MP0003866_abnormal_defecation | 0.98135284 |
| 103 | MP0008872_abnormal_physiological_respon | 0.97925222 |
| 104 | MP0000767_abnormal_smooth_muscle | 0.96719233 |
| 105 | MP0004043_abnormal_pH_regulation | 0.96309348 |
| 106 | MP0003300_gastrointestinal_ulcer | 0.96253986 |
| 107 | MP0003634_abnormal_glial_cell | 0.95633597 |
| 108 | MP0000681_abnormal_thyroid_gland | 0.95552151 |
| 109 | MP0002736_abnormal_nociception_after | 0.94632697 |
| 110 | MP0008775_abnormal_heart_ventricle | 0.94042982 |
| 111 | MP0004085_abnormal_heartbeat | 0.93048308 |
| 112 | MP0004924_abnormal_behavior | 0.91802192 |
| 113 | MP0005386_behavior/neurological_phenoty | 0.91802192 |
| 114 | MP0000759_abnormal_skeletal_muscle | 0.91267766 |
| 115 | MP0008961_abnormal_basal_metabolism | 0.91194556 |
| 116 | MP0004947_skin_inflammation | 0.90099709 |
| 117 | MP0002733_abnormal_thermal_nociception | 0.88854044 |
| 118 | MP0001986_abnormal_taste_sensitivity | 0.85618826 |
| 119 | MP0005666_abnormal_adipose_tissue | 0.85383323 |
| 120 | MP0000747_muscle_weakness | 0.84085061 |
| 121 | MP0002078_abnormal_glucose_homeostasis | 0.83178197 |
| 122 | MP0000249_abnormal_blood_vessel | 0.81664462 |
| 123 | MP0004811_abnormal_neuron_physiology | 0.81046174 |
| 124 | MP0001970_abnormal_pain_threshold | 0.80876911 |
| 125 | MP0000230_abnormal_systemic_arterial | 0.79327052 |
| 126 | MP0004510_myositis | 0.79191203 |
| 127 | MP0001765_abnormal_ion_homeostasis | 0.79167729 |
| 128 | MP0000343_altered_response_to | 0.79073460 |
| 129 | MP0003763_abnormal_thymus_physiology | 0.79067613 |
| 130 | MP0004019_abnormal_vitamin_homeostasis | 0.78854020 |
| 131 | MP0006138_congestive_heart_failure | 0.78801671 |
| 132 | MP0001664_abnormal_digestion | 0.78662122 |
| 133 | MP0000858_altered_metastatic_potential | 0.78641014 |
| 134 | MP0002971_abnormal_brown_adipose | 0.78543569 |
| 135 | MP0002249_abnormal_larynx_morphology | 0.78467769 |
| 136 | MP0005390_skeleton_phenotype | 0.78414389 |
| 137 | MP0001544_abnormal_cardiovascular_syste | 0.78205946 |
| 138 | MP0005385_cardiovascular_system_phenoty | 0.78205946 |
| 139 | MP0002090_abnormal_vision | 0.76532770 |
| 140 | MP0004185_abnormal_adipocyte_glucose | 0.75634433 |
| 141 | MP0005023_abnormal_wound_healing | 0.75203712 |
| 142 | MP0005187_abnormal_penis_morphology | 0.74837160 |
| 143 | MP0003045_fibrosis | 0.73893578 |
| 144 | MP0001663_abnormal_digestive_system | 0.73836520 |
| 145 | MP0001542_abnormal_bone_strength | 0.73615594 |
| 146 | MP0005508_abnormal_skeleton_morphology | 0.73587561 |
| 147 | MP0002896_abnormal_bone_mineralization | 0.72349670 |
| 148 | MP0004145_abnormal_muscle_electrophysio | 0.72330023 |
| 149 | MP0003631_nervous_system_phenotype | 0.70722458 |
| 150 | MP0002108_abnormal_muscle_morphology | 0.69824363 |
| 151 | MP0001502_abnormal_circadian_rhythm | 0.68803899 |
| 152 | MP0001851_eye_inflammation | 0.68310167 |
| 153 | MP0006036_abnormal_mitochondrial_physio | 0.67060627 |
| 154 | MP0002089_abnormal_postnatal_growth/wei | 0.66775943 |
| 155 | MP0006082_CNS_inflammation | 0.66694541 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 4.27607688 |
| 2 | Deep venous thrombosis (HP:0002625) | 4.05653809 |
| 3 | Protrusio acetabuli (HP:0003179) | 4.01932330 |
| 4 | Bundle branch block (HP:0011710) | 3.71038914 |
| 5 | Obstructive sleep apnea (HP:0002870) | 3.56095913 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 3.45486766 |
| 7 | Xanthomatosis (HP:0000991) | 3.33144599 |
| 8 | Abnormality of the nasal mucosa (HP:0000433) | 3.31466089 |
| 9 | Ventricular fibrillation (HP:0001663) | 3.17212036 |
| 10 | Sudden death (HP:0001699) | 3.17190508 |
| 11 | Increased variability in muscle fiber diameter (HP:0003557) | 3.15659314 |
| 12 | Right ventricular cardiomyopathy (HP:0011663) | 3.13265197 |
| 13 | Neurofibrillary tangles (HP:0002185) | 3.10373128 |
| 14 | Focal motor seizures (HP:0011153) | 3.09359774 |
| 15 | Supranuclear gaze palsy (HP:0000605) | 3.07808882 |
| 16 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.04408789 |
| 17 | Exercise-induced myalgia (HP:0003738) | 3.02254090 |
| 18 | Nasal polyposis (HP:0100582) | 3.02112391 |
| 19 | Aortic aneurysm (HP:0004942) | 3.00805592 |
| 20 | Vascular tortuosity (HP:0004948) | 3.00298799 |
| 21 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.99961292 |
| 22 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.97581334 |
| 23 | Action tremor (HP:0002345) | 2.92657133 |
| 24 | Syncope (HP:0001279) | 2.89839498 |
| 25 | Heart block (HP:0012722) | 2.89787796 |
| 26 | Myoglobinuria (HP:0002913) | 2.87454581 |
| 27 | Hyperlipoproteinemia (HP:0010980) | 2.86192284 |
| 28 | Ankle clonus (HP:0011448) | 2.85876828 |
| 29 | Dysmetric saccades (HP:0000641) | 2.82238731 |
| 30 | Visual hallucinations (HP:0002367) | 2.81456915 |
| 31 | Complement deficiency (HP:0004431) | 2.81414190 |
| 32 | Premature rupture of membranes (HP:0001788) | 2.80675153 |
| 33 | Abnormal atrioventricular conduction (HP:0005150) | 2.76456676 |
| 34 | Arterial tortuosity (HP:0005116) | 2.75249813 |
| 35 | Annular pancreas (HP:0001734) | 2.74942657 |
| 36 | Hypoglycemic coma (HP:0001325) | 2.74823498 |
| 37 | Cerebral aneurysm (HP:0004944) | 2.70282626 |
| 38 | Ketosis (HP:0001946) | 2.70233453 |
| 39 | Hyperammonemia (HP:0001987) | 2.69925574 |
| 40 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.67940199 |
| 41 | Exercise-induced muscle cramps (HP:0003710) | 2.67144358 |
| 42 | Abnormality of binocular vision (HP:0011514) | 2.66300585 |
| 43 | Diplopia (HP:0000651) | 2.66300585 |
| 44 | Papilledema (HP:0001085) | 2.64198643 |
| 45 | Focal seizures (HP:0007359) | 2.61828269 |
| 46 | Ketoacidosis (HP:0001993) | 2.56050996 |
| 47 | Hypoalphalipoproteinemia (HP:0003233) | 2.55778942 |
| 48 | Prolonged partial thromboplastin time (HP:0003645) | 2.54924181 |
| 49 | Cerebral inclusion bodies (HP:0100314) | 2.54068611 |
| 50 | Vertebral compression fractures (HP:0002953) | 2.53328248 |
| 51 | Atrioventricular block (HP:0001678) | 2.52434237 |
| 52 | Prolonged QT interval (HP:0001657) | 2.44205944 |
| 53 | Aortic dissection (HP:0002647) | 2.41750543 |
| 54 | Ventricular arrhythmia (HP:0004308) | 2.38987737 |
| 55 | Abnormality of the lower motor neuron (HP:0002366) | 2.38739464 |
| 56 | Impaired social interactions (HP:0000735) | 2.35600095 |
| 57 | Abnormal social behavior (HP:0012433) | 2.35600095 |
| 58 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.34732184 |
| 59 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.34732184 |
| 60 | Torticollis (HP:0000473) | 2.33659079 |
| 61 | Spinal rigidity (HP:0003306) | 2.33411447 |
| 62 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.33299232 |
| 63 | Palpitations (HP:0001962) | 2.31715251 |
| 64 | Absent/shortened dynein arms (HP:0200106) | 2.31104821 |
| 65 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.31104821 |
| 66 | Rhinitis (HP:0012384) | 2.30294501 |
| 67 | Atelectasis (HP:0100750) | 2.27980238 |
| 68 | Dilatation of the ascending aorta (HP:0005111) | 2.27634916 |
| 69 | Distal upper limb amyotrophy (HP:0007149) | 2.25913278 |
| 70 | Upper limb amyotrophy (HP:0009129) | 2.25913278 |
| 71 | Turricephaly (HP:0000262) | 2.24103075 |
| 72 | Hemorrhage of the eye (HP:0011885) | 2.22664042 |
| 73 | Type 1 muscle fiber predominance (HP:0003803) | 2.21885216 |
| 74 | Epidermoid cyst (HP:0200040) | 2.21820194 |
| 75 | Postural instability (HP:0002172) | 2.21435475 |
| 76 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.20878578 |
| 77 | Dysostosis multiplex (HP:0000943) | 2.19833085 |
| 78 | Sensorimotor neuropathy (HP:0007141) | 2.19199006 |
| 79 | Hypolipoproteinemia (HP:0010981) | 2.18832006 |
| 80 | Skin nodule (HP:0200036) | 2.18390279 |
| 81 | Abnormal ciliary motility (HP:0012262) | 2.17934345 |
| 82 | Hypobetalipoproteinemia (HP:0003563) | 2.17058067 |
| 83 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.15489456 |
| 84 | Pheochromocytoma (HP:0002666) | 2.14090573 |
| 85 | Abnormal EKG (HP:0003115) | 2.13223227 |
| 86 | Focal dystonia (HP:0004373) | 2.12762224 |
| 87 | Hyperglycinemia (HP:0002154) | 2.11991869 |
| 88 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.11874289 |
| 89 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.11874289 |
| 90 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.11874289 |
| 91 | Atrial fibrillation (HP:0005110) | 2.10663892 |
| 92 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.10385197 |
| 93 | Mucopolysacchariduria (HP:0008155) | 2.10385197 |
| 94 | Ventricular tachycardia (HP:0004756) | 2.09461340 |
| 95 | Hyperactive renin-angiotensin system (HP:0000841) | 2.09347234 |
| 96 | Poor eye contact (HP:0000817) | 2.08698678 |
| 97 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.08048854 |
| 98 | Abnormality of the Achilles tendon (HP:0005109) | 2.07867788 |
| 99 | Cholelithiasis (HP:0001081) | 2.07412887 |
| 100 | Abnormal gallbladder physiology (HP:0012438) | 2.06812126 |
| 101 | Cholecystitis (HP:0001082) | 2.06812126 |
| 102 | Status epilepticus (HP:0002133) | 2.06159606 |
| 103 | Shallow orbits (HP:0000586) | 2.05881231 |
| 104 | Dysdiadochokinesis (HP:0002075) | 2.04922204 |
| 105 | Axonal loss (HP:0003447) | 2.04787107 |
| 106 | Hyperglycinuria (HP:0003108) | 2.04202718 |
| 107 | Muscle fiber splitting (HP:0003555) | 2.03738934 |
| 108 | Distal lower limb muscle weakness (HP:0009053) | 2.03587138 |
| 109 | Craniofacial dystonia (HP:0012179) | 2.02722574 |
| 110 | Gout (HP:0001997) | 2.02672512 |
| 111 | Generalized tonic-clonic seizures (HP:0002069) | 2.02640752 |
| 112 | Abnormality of the common coagulation pathway (HP:0010990) | 2.02464877 |
| 113 | Primary atrial arrhythmia (HP:0001692) | 2.02264292 |
| 114 | Stridor (HP:0010307) | 2.02009509 |
| 115 | Cervical subluxation (HP:0003308) | 2.00740023 |
| 116 | Neonatal onset (HP:0003623) | 1.99684529 |
| 117 | Late onset (HP:0003584) | 1.98747594 |
| 118 | Aneurysm (HP:0002617) | 1.98145474 |
| 119 | Abnormality of complement system (HP:0005339) | 1.97734562 |
| 120 | Abnormal gallbladder morphology (HP:0012437) | 1.96132354 |
| 121 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.95742388 |
| 122 | Hypercortisolism (HP:0001578) | 1.95684650 |
| 123 | Neuronal loss in central nervous system (HP:0002529) | 1.95150804 |
| 124 | Bladder diverticulum (HP:0000015) | 1.94119559 |
| 125 | Anxiety (HP:0000739) | 1.94030980 |
| 126 | Neonatal short-limb short stature (HP:0008921) | 1.93263466 |
| 127 | Spinal cord compression (HP:0002176) | 1.93044743 |
| 128 | Spontaneous abortion (HP:0005268) | 1.92372314 |
| 129 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.91798467 |
| 130 | Myotonia (HP:0002486) | 1.91351168 |
| 131 | Ileus (HP:0002595) | 1.90968448 |
| 132 | Truncal ataxia (HP:0002078) | 1.90959036 |
| 133 | Depression (HP:0000716) | 1.89836186 |
| 134 | Growth hormone excess (HP:0000845) | 1.89326620 |
| 135 | Systemic lupus erythematosus (HP:0002725) | 1.89200312 |
| 136 | Hyporeflexia of lower limbs (HP:0002600) | 1.88965037 |
| 137 | Emphysema (HP:0002097) | 1.87888641 |
| 138 | Polygenic inheritance (HP:0010982) | 1.87209164 |
| 139 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.87002225 |
| 140 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.86854136 |
| 141 | Abnormality of glycine metabolism (HP:0010895) | 1.86854136 |
| 142 | Wormian bones (HP:0002645) | 1.86712934 |
| 143 | Supraventricular tachycardia (HP:0004755) | 1.85904068 |
| 144 | Rapidly progressive (HP:0003678) | 1.85585427 |
| 145 | Epileptic encephalopathy (HP:0200134) | 1.85026453 |
| 146 | Hand muscle atrophy (HP:0009130) | 1.84352702 |
| 147 | Broad metatarsal (HP:0001783) | 1.84291937 |
| 148 | Flat acetabular roof (HP:0003180) | 1.83995902 |
| 149 | Abnormal eating behavior (HP:0100738) | 1.83897347 |
| 150 | Stroke (HP:0001297) | 1.83832286 |
| 151 | Asymmetric septal hypertrophy (HP:0001670) | 1.83313699 |
| 152 | Supraventricular arrhythmia (HP:0005115) | 1.81460722 |
| 153 | EMG: myopathic abnormalities (HP:0003458) | 1.81447575 |
| 154 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.80661772 |
| 155 | Joint stiffness (HP:0001387) | 1.80410914 |
| 156 | Achilles tendon contracture (HP:0001771) | 1.79558367 |
| 157 | Thin bony cortex (HP:0002753) | 1.79434874 |
| 158 | Chronic bronchitis (HP:0004469) | 1.79182146 |
| 159 | Increased connective tissue (HP:0009025) | 1.78593622 |
| 160 | Muscle stiffness (HP:0003552) | 1.77143165 |
| 161 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.76731484 |
| 162 | Hemiplegia (HP:0002301) | 1.75346218 |
| 163 | Long toe (HP:0010511) | 1.74694510 |
| 164 | Hyperventilation (HP:0002883) | 1.74338042 |
| 165 | Abnormality of the intrinsic pathway (HP:0010989) | 1.74190024 |
| 166 | Foot dorsiflexor weakness (HP:0009027) | 1.73990294 |
| 167 | Dicarboxylic aciduria (HP:0003215) | 1.73660760 |
| 168 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.73660760 |
| 169 | Mitral regurgitation (HP:0001653) | 1.72824585 |
| 170 | Hypertriglyceridemia (HP:0002155) | 1.72658361 |
| 171 | Progressive cerebellar ataxia (HP:0002073) | 1.72315086 |
| 172 | Tetraplegia (HP:0002445) | 1.71591560 |
| 173 | Mitral stenosis (HP:0001718) | 1.71506529 |
| 174 | Akinesia (HP:0002304) | 1.71131985 |
| 175 | Bronchiectasis (HP:0002110) | 1.70989541 |
| 176 | Rhabdomyolysis (HP:0003201) | 1.70911171 |
| 177 | Blue sclerae (HP:0000592) | 1.69017580 |
| 178 | Insomnia (HP:0100785) | 1.67083734 |
| 179 | Acanthosis nigricans (HP:0000956) | 1.66922677 |
| 180 | Hypoventilation (HP:0002791) | 1.66655952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK1 | 3.13349669 |
| 2 | EPHA4 | 3.11966938 |
| 3 | LMTK2 | 2.74422826 |
| 4 | MAP3K9 | 2.62324925 |
| 5 | PIK3CA | 2.55480313 |
| 6 | TRIB3 | 2.41576573 |
| 7 | DAPK2 | 2.39321238 |
| 8 | KSR2 | 2.36027002 |
| 9 | CAMKK1 | 2.24894156 |
| 10 | NTRK3 | 2.23175937 |
| 11 | PKN2 | 2.11958251 |
| 12 | MAPK15 | 2.06002944 |
| 13 | PRKD3 | 2.02610941 |
| 14 | TAOK1 | 1.89868327 |
| 15 | PAK6 | 1.84942787 |
| 16 | FRK | 1.75284471 |
| 17 | PHKG2 | 1.68351474 |
| 18 | PHKG1 | 1.68351474 |
| 19 | MAP2K4 | 1.59188396 |
| 20 | MINK1 | 1.55639649 |
| 21 | MARK2 | 1.50471660 |
| 22 | MAP3K4 | 1.47837716 |
| 23 | TTN | 1.43534170 |
| 24 | NEK1 | 1.43167522 |
| 25 | ICK | 1.42398469 |
| 26 | MAP3K7 | 1.41408717 |
| 27 | NTRK1 | 1.40306513 |
| 28 | SIK1 | 1.40304907 |
| 29 | STK38 | 1.38213240 |
| 30 | EEF2K | 1.36990576 |
| 31 | MYLK | 1.36277063 |
| 32 | PINK1 | 1.35325073 |
| 33 | MAP3K2 | 1.33842676 |
| 34 | RIPK4 | 1.32140402 |
| 35 | DMPK | 1.31660108 |
| 36 | TESK1 | 1.31089011 |
| 37 | MST1R | 1.24092626 |
| 38 | SMG1 | 1.17257412 |
| 39 | FGFR4 | 1.15521241 |
| 40 | FES | 1.13245250 |
| 41 | SGK3 | 1.10852016 |
| 42 | UHMK1 | 1.10678568 |
| 43 | MARK1 | 1.08888823 |
| 44 | BCKDK | 1.07981083 |
| 45 | ZAP70 | 1.07192558 |
| 46 | GRK6 | 1.06137194 |
| 47 | PDPK1 | 1.04240901 |
| 48 | EPHB1 | 1.03783372 |
| 49 | PRKD2 | 1.01725332 |
| 50 | MAP4K1 | 1.00418071 |
| 51 | RET | 0.98592787 |
| 52 | PRKCH | 0.97861744 |
| 53 | PAK3 | 0.96584684 |
| 54 | MAP3K1 | 0.96350816 |
| 55 | CAMKK2 | 0.95382932 |
| 56 | PDK1 | 0.93406403 |
| 57 | DAPK1 | 0.93287518 |
| 58 | CDK5 | 0.93283205 |
| 59 | PDK4 | 0.92513258 |
| 60 | PDK3 | 0.92513258 |
| 61 | LATS2 | 0.92051498 |
| 62 | CAMK2D | 0.91464564 |
| 63 | MAP3K13 | 0.91011815 |
| 64 | PTK6 | 0.90828299 |
| 65 | MAP2K1 | 0.90720951 |
| 66 | ERN1 | 0.90476981 |
| 67 | PDGFRA | 0.89372635 |
| 68 | ARAF | 0.86007508 |
| 69 | TBK1 | 0.85201748 |
| 70 | MAP2K3 | 0.83965316 |
| 71 | STK11 | 0.81483256 |
| 72 | TYK2 | 0.81261995 |
| 73 | DAPK3 | 0.80387857 |
| 74 | SGK2 | 0.80209121 |
| 75 | TGFBR2 | 0.79065440 |
| 76 | PRKCG | 0.78595711 |
| 77 | MAP2K7 | 0.77891073 |
| 78 | CDC42BPA | 0.77870120 |
| 79 | MAPK7 | 0.77583004 |
| 80 | CSK | 0.77417464 |
| 81 | TAOK2 | 0.75917741 |
| 82 | RPS6KA2 | 0.75859612 |
| 83 | ALK | 0.74434699 |
| 84 | MOS | 0.73868749 |
| 85 | BMX | 0.72797470 |
| 86 | CAMK1 | 0.72647296 |
| 87 | KSR1 | 0.72557942 |
| 88 | PRPF4B | 0.72064676 |
| 89 | GRK5 | 0.71151510 |
| 90 | SGK494 | 0.70709476 |
| 91 | SGK223 | 0.70709476 |
| 92 | PRKG2 | 0.70166021 |
| 93 | DDR2 | 0.68359555 |
| 94 | PTK2B | 0.68258346 |
| 95 | CAMK2G | 0.65890421 |
| 96 | TNK2 | 0.65501009 |
| 97 | MAPKAPK3 | 0.65110955 |
| 98 | PTK2 | 0.64072952 |
| 99 | CAMK2A | 0.62380916 |
| 100 | NTRK2 | 0.62321117 |
| 101 | MAP3K3 | 0.62313601 |
| 102 | PRKAA1 | 0.58309711 |
| 103 | MAPK4 | 0.57520944 |
| 104 | OBSCN | 0.57304263 |
| 105 | HIPK2 | 0.56505102 |
| 106 | PRKCZ | 0.55526281 |
| 107 | EPHB2 | 0.55073949 |
| 108 | FGFR3 | 0.55002704 |
| 109 | TYRO3 | 0.54590951 |
| 110 | MAP3K12 | 0.54297099 |
| 111 | MAP2K2 | 0.53999701 |
| 112 | ROCK1 | 0.53995219 |
| 113 | MAP2K6 | 0.52990425 |
| 114 | LIMK1 | 0.52948922 |
| 115 | PRKACG | 0.52862680 |
| 116 | SGK1 | 0.52585321 |
| 117 | CAMK4 | 0.52263863 |
| 118 | PRKD1 | 0.49877356 |
| 119 | NME1 | 0.48971912 |
| 120 | DYRK1B | 0.48609322 |
| 121 | JAK1 | 0.47966000 |
| 122 | ROCK2 | 0.47659979 |
| 123 | INSRR | 0.46149347 |
| 124 | MAPK12 | 0.45100855 |
| 125 | JAK2 | 0.44733942 |
| 126 | TIE1 | 0.44214826 |
| 127 | PDGFRB | 0.44104649 |
| 128 | SIK2 | 0.43590277 |
| 129 | CAMK2B | 0.43546257 |
| 130 | MAP3K11 | 0.43345703 |
| 131 | ERBB2 | 0.43246538 |
| 132 | PRKAA2 | 0.42640021 |
| 133 | MAPK11 | 0.42282612 |
| 134 | RAF1 | 0.42111541 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.55133336 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.07223187 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.46538241 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.36902189 |
| 5 | Bile secretion_Homo sapiens_hsa04976 | 2.05671061 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.91982977 |
| 7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.89534015 |
| 8 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.86504356 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.82461916 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.71108945 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.70959022 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.64935897 |
| 13 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.64820163 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.56257298 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.54374429 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.48139483 |
| 17 | Olfactory transduction_Homo sapiens_hsa04740 | 1.46499259 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.45358375 |
| 19 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.43675714 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.43252137 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.43124138 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.37815150 |
| 23 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.37476026 |
| 24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.36408452 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.30733048 |
| 26 | Circadian entrainment_Homo sapiens_hsa04713 | 1.28678953 |
| 27 | Salivary secretion_Homo sapiens_hsa04970 | 1.27113218 |
| 28 | GABAergic synapse_Homo sapiens_hsa04727 | 1.26615519 |
| 29 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.24377483 |
| 30 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.23142931 |
| 31 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.18354378 |
| 32 | Insulin secretion_Homo sapiens_hsa04911 | 1.17234105 |
| 33 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.17133017 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.14814872 |
| 35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.12006143 |
| 36 | Nicotine addiction_Homo sapiens_hsa05033 | 1.11825349 |
| 37 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.11519120 |
| 38 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10945115 |
| 39 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.08591082 |
| 40 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.08122961 |
| 41 | Long-term potentiation_Homo sapiens_hsa04720 | 1.07717027 |
| 42 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.05679973 |
| 43 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.04099475 |
| 44 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.02584473 |
| 45 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.98563469 |
| 46 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.98547067 |
| 47 | Morphine addiction_Homo sapiens_hsa05032 | 0.97301921 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.95399170 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.95241219 |
| 50 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.94901002 |
| 51 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.94742702 |
| 52 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.94300470 |
| 53 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.91825174 |
| 54 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.90711014 |
| 55 | Endocytosis_Homo sapiens_hsa04144 | 0.89985164 |
| 56 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.89819384 |
| 57 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.89710138 |
| 58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89597495 |
| 59 | Focal adhesion_Homo sapiens_hsa04510 | 0.89080310 |
| 60 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.86907275 |
| 61 | Renin secretion_Homo sapiens_hsa04924 | 0.86661957 |
| 62 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.86540049 |
| 63 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.85952651 |
| 64 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.83753892 |
| 65 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.83346268 |
| 66 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.82690797 |
| 67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.81769011 |
| 68 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.81462135 |
| 69 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.79567616 |
| 70 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.79159908 |
| 71 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78428689 |
| 72 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.77824113 |
| 73 | Amoebiasis_Homo sapiens_hsa05146 | 0.76571508 |
| 74 | Peroxisome_Homo sapiens_hsa04146 | 0.76247332 |
| 75 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.75709540 |
| 76 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.75364855 |
| 77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.74709690 |
| 78 | Melanogenesis_Homo sapiens_hsa04916 | 0.74409126 |
| 79 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.73990702 |
| 80 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.73958517 |
| 81 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.73819088 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.72930752 |
| 83 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.72282878 |
| 84 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.71726195 |
| 85 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.71331033 |
| 86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.71007896 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70953748 |
| 88 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.70769343 |
| 89 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.70626151 |
| 90 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.69766927 |
| 91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69405685 |
| 92 | Pertussis_Homo sapiens_hsa05133 | 0.68284776 |
| 93 | Lysosome_Homo sapiens_hsa04142 | 0.68144684 |
| 94 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.67805231 |
| 95 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.67425057 |
| 96 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.66804264 |
| 97 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.66406029 |
| 98 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.66030314 |
| 99 | ABC transporters_Homo sapiens_hsa02010 | 0.64268604 |
| 100 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.64184902 |
| 101 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.64095059 |
| 102 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63614749 |
| 103 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.63556758 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.63156309 |
| 105 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.62842970 |
| 106 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.62607256 |
| 107 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.62556658 |
| 108 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61807241 |
| 109 | Cocaine addiction_Homo sapiens_hsa05030 | 0.61388859 |
| 110 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.60905387 |
| 111 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60716619 |
| 112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60244458 |
| 113 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.59736631 |
| 114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59584946 |
| 115 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59249285 |
| 116 | Malaria_Homo sapiens_hsa05144 | 0.59045266 |
| 117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58635341 |
| 118 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.58561037 |
| 119 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.58441891 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58145053 |
| 121 | Histidine metabolism_Homo sapiens_hsa00340 | 0.58033128 |
| 122 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57724957 |
| 123 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56990338 |
| 124 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56705355 |
| 125 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56689284 |
| 126 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55480209 |
| 127 | Platelet activation_Homo sapiens_hsa04611 | 0.54900944 |
| 128 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.54792561 |
| 129 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.54296392 |
| 130 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54268048 |
| 131 | Sulfur relay system_Homo sapiens_hsa04122 | 0.53854793 |
| 132 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.53657750 |
| 133 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.52169614 |
| 134 | Gap junction_Homo sapiens_hsa04540 | 0.51844231 |
| 135 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.51839327 |
| 136 | Hepatitis C_Homo sapiens_hsa05160 | 0.50758628 |
| 137 | Circadian rhythm_Homo sapiens_hsa04710 | 0.49938265 |
| 138 | Mineral absorption_Homo sapiens_hsa04978 | 0.49380182 |
| 139 | Taste transduction_Homo sapiens_hsa04742 | 0.49051637 |
| 140 | Glioma_Homo sapiens_hsa05214 | 0.48986187 |
| 141 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.48410818 |
| 142 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.48203074 |
| 143 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.48067363 |
| 144 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47834932 |
| 145 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45847245 |
| 146 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.44427221 |
| 147 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43327700 |
| 148 | Prion diseases_Homo sapiens_hsa05020 | 0.42457594 |
| 149 | Long-term depression_Homo sapiens_hsa04730 | 0.42036317 |
| 150 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.41270790 |
| 151 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.40848571 |

